Overview

Treatment of Keratoconus With Advanced CXL-II

Status:
Unknown status

Trial end date:
2019-10-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine whether individualized, topography-based corneal crosslinking for keratoconus can improve the optical outcomes of the treatment.

Phase:

Phase 2

Details

Lead Sponsor:

Umeå University

Treatments:

Anesthetics
Riboflavin